Drug intelligence / Profile preview

juhong keli

Development stage: Unknown
Lead developer: Liaoning Jindan Pharmaceutical
Administration: Oral

Overview

Juhong Keli is a traditional Chinese medicine (TCM) granule formulation manufactured by Liaoning Jindan Pharmaceutical. It is an approved medication in China used to treat cough, excessive phlegm, and chest congestion associated with conditions such as bronchitis. The formulation is based on a combination of several herbal ingredients, with Exocarpium Citri Grandis (Juhong) serving as the principal component. Its therapeutic actions include resolving phlegm, suppressing cough, and regulating qi to alleviate respiratory distress. The product is part of a long-standing tradition of respiratory treatments in Chinese pharmacopoeia and is widely utilized for its ability to clear lung heat and transform dampness.

Brand names: 橘红颗粒Juhong Keli
Other names: Juhong Granules

Beyond the preview

Go deeper on juhong keli.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on juhong keli.

Explore the full profile